B

Barinthus Biotherapeutics plc
D

BRNS

1.01000
USD
-0.04
(-3.81%)
مغلق
حجم التداول
5
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
40,742,789
أصول ذات صلة
A
ADNT
-0.140
(-0.61%)
22.730 USD
A
ALV
-0.330
(-0.28%)
117.700 USD
APTV
APTV
-1.290
(-1.83%)
69.260 USD
B
BWA
-0.400
(-1.12%)
35.400 USD
F
F
-0.135
(-1.13%)
11.770 USD
GM
GM
0.250
(0.47%)
53.370 USD
HMC
HMC
-0.065
(-0.21%)
30.705 USD
L
LEA
-1.100
(-1.02%)
106.590 USD
L
LKQ
-0.650
(-1.66%)
38.600 USD
TSLA
TSLA
3.56
(1.15%)
313.50 USD
T
TEN
0.335
(1.64%)
20.745 USD
المزيد
المقالات

العنوان: Barinthus Biotherapeutics plc

القطاع: Healthcare
الصناعة: Biotechnology
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.